Viewing Study NCT00082394

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-28 @ 12:03 AM
Study NCT ID: NCT00082394
Status: COMPLETED
Last Update Posted: 2017-05-24
First Post: 2004-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Infection, Human Immunodeficiency Virus I View
None HIV Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None safety View
None drug efficacy View
None TRIZIVIR View
None tolerability View
None COMBIVIR View
None HIV View
None atazanavir View